Logo - springer
Slogan - springer

Medicine - Internal Medicine | Bone Drugs in Pediatrics - Efficacy and Challenges

Bone Drugs in Pediatrics

Efficacy and Challenges

Klein, Gordon (Ed.)

2014, XIII, 233 p. 45 illus., 28 illus. in color.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$109.00

(net) price for USA

ISBN 978-1-4899-7436-5

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$139.00

(net) price for USA

ISBN 978-1-4899-7435-8

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • Presents evidence for the use of certain drugs in the treatment and prevention of bone loss in children
  • Balances the pros and cons of utilizing these drugs in the pediatric population
  • Highlights the potential for future use of these and other drugs with children
Bone Drugs in Pediatrics brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their use. Beginning with a discussion of developmental pharmacokinetics and drug development for pediatric diseases where bone loss occurs, such as osteogenesis imperfecta, the physiology of pediatric bone and how best to monitor the safety and efficacy of these drugs is presented. The pros and cons of utilizing the drugs themselves – such as bisphosphonates, anti-resorptives and anabolic agents – within the pediatric population are carefully considered, with an eye toward safe and effective integration. The potential use of drugs in future treatment is also highlighted. On the whole, Bone Drugs in Pediatrics is a cogent presentation of the ongoing debate surrounding the potential for pharmacological interventions in pediatric bone loss.

Content Level » Professional/practitioner

Keywords » Anti-resorptive - Bisphosphonate - Growth hormone - Oxandralone - Pediatric bone drugs - Pediatric bone loss - Pediatric pharmacology

Related subjects » Internal Medicine - Orthopedics - Pediatrics

Table of contents / Sample pages 

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Endocrinology.